Clear Search sequence regions


  • apoptosis (1)
  • cisplatin (1)
  • humans (1)
  • iridium (4)
  • Sizes of these terms reflect their relevance to your search.

    Due to multidrug resistance and the high risk of recurrence, effective and less toxic alternative pancreatic cancer treatments are urgently needed. Pancreatic cancer cells are highly resistant to apoptosis but sensitive to ferroptosis. In this study, an innovative nanoplatform (AsIr@PDA) was developed by electrostatic adsorption of a cationic iridium complex (IrFN) onto two-dimensional (2D) arsenene nanosheets. This nanoplatform exhibits superior ferroptosis-inducing effects with high drug loading capacity and, importantly, excellent anti-cancer immune activation function, leading to efficient elimination of pancreatic tumors with no observable side effects. Interestingly, AsIr@PDA significantly prevents the recurrence of pancreatic cancer in vivo when compared with a cisplatin-loaded nanoplatform. This designed nanoplatform demonstrated superior therapeutic efficacy by synergistic ferroptosis-induced chemotherapy with immunotherapy via an all-in-one strategy, providing new insights for future pancreatic cancer therapy. © 2024 Wiley‐VCH GmbH.

    Citation

    Xinyang Zhao, Xingyun Wang, Wei Zhang, Tian Tian, Jingyi Zhang, Jing Wang, Wei Wei, Zijian Guo, Jing Zhao, Xiuxiu Wang. A Ferroptosis-Inducing Arsenene-Iridium Nanoplatform for Synergistic Immunotherapy in Pancreatic Cancer. Angewandte Chemie (International ed. in English). 2024 Apr 08;63(15):e202400829

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 38349715

    View Full Text